1. Home
  2. CVRX vs ARAI Comparison

CVRX vs ARAI Comparison

Compare CVRX & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • ARAI
  • Stock Information
  • Founded
  • CVRX 2000
  • ARAI 2020
  • Country
  • CVRX United States
  • ARAI United States
  • Employees
  • CVRX N/A
  • ARAI N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ARAI Diversified Commercial Services
  • Sector
  • CVRX Health Care
  • ARAI Finance
  • Exchange
  • CVRX Nasdaq
  • ARAI Nasdaq
  • Market Cap
  • CVRX 203.9M
  • ARAI 190.6M
  • IPO Year
  • CVRX 2021
  • ARAI N/A
  • Fundamental
  • Price
  • CVRX $10.68
  • ARAI $4.86
  • Analyst Decision
  • CVRX Buy
  • ARAI
  • Analyst Count
  • CVRX 7
  • ARAI 0
  • Target Price
  • CVRX $14.00
  • ARAI N/A
  • AVG Volume (30 Days)
  • CVRX 195.1K
  • ARAI 602.5K
  • Earning Date
  • CVRX 11-05-2025
  • ARAI 08-14-2025
  • Dividend Yield
  • CVRX N/A
  • ARAI N/A
  • EPS Growth
  • CVRX N/A
  • ARAI N/A
  • EPS
  • CVRX N/A
  • ARAI N/A
  • Revenue
  • CVRX $54,652,000.00
  • ARAI $90,725.00
  • Revenue This Year
  • CVRX $11.32
  • ARAI N/A
  • Revenue Next Year
  • CVRX $18.58
  • ARAI N/A
  • P/E Ratio
  • CVRX N/A
  • ARAI N/A
  • Revenue Growth
  • CVRX 23.11
  • ARAI N/A
  • 52 Week Low
  • CVRX $4.30
  • ARAI $3.03
  • 52 Week High
  • CVRX $18.55
  • ARAI $40.00
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 69.71
  • ARAI N/A
  • Support Level
  • CVRX $9.71
  • ARAI N/A
  • Resistance Level
  • CVRX $11.11
  • ARAI N/A
  • Average True Range (ATR)
  • CVRX 0.54
  • ARAI 0.00
  • MACD
  • CVRX 0.05
  • ARAI 0.00
  • Stochastic Oscillator
  • CVRX 76.63
  • ARAI 0.00

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: